12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Venus Concept (NASDAQ:VERO) shares increased by 135.2% to $1.38 during Friday’s pre-market session. The market value of…
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers IGM Biosciences (NASDAQ:IGMS) shares increased by 36.6% to $11.49 during Wednesday’s regular session. The market value of…
Indaptus Therapeutics First Patient Received Multiple Doses Of Decoy20, The Company’s Broad-Based, “Pulse-Prime” Immuno-Oncology Therapy For Advanced Solid Tumors
First-in-human trial confirms "Pulse-Prime" hypothesis targeting stimulation of innate and adaptive immune systemsInvestigational package of broad immune agonists derived from Gram-negative bacteria which induces dozens
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers Twist Bioscience (NASDAQ:TWST) stock increased by 14.1% to $36.51 during Thursday’s after-market session. The company’s market cap…
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers Pulmonx (NASDAQ:LUNG) shares rose 29.5% to $10.0 during Wednesday’s after-market session. The market value of their outstanding…
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Protara Therapeutics (NASDAQ:TARA) stock increased by 40.3% to $5.64 during Friday’s pre-market session. The market value of…
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Carbon Revolution Public Limited (NASDAQ: CREV) shares jumped 396.2% to $145.49 after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge Capital Acquisition Corp.
Indaptus Therapeutics To Present Pharmacodynamic Immune And Pharmacokinetic Results With Patients From First Cohort Of Ongoing Phase 1 Study Of Decoy20 At Cancer Immunotherapy Meeting
Poster to be presented at 38th Annual Meeting of the Society for Immunotherapy of Cancer on November 4, 2023 NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (NASDAQ:INDP) announces it will be
Indaptus Therapeutics Doses First Patient In Second Cohort Of Single Dose Ranging Study Of Decoy20
Indaptus Therapeutics, Inc. (NASDAQ:INDP) ("Indaptus" or the "Company") announces dosing of the first patient in the second cohort of patients to receive a single dose of Decoy20 in the INDP-D101 trial. This cohort dose
Around $15M Bet On Taysha Gene Therapies? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed lower by around 180 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.